Company / Cash per Share
Jade Biosciences, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.18
FY2024
5-year range
$0.89 / $18.88
FY2020-FY2024
Trend
+32.4%
vs FY2023
Sector context
#132 of 203
Health Care
What the data says
At $1.18, Jade Biosciences, Inc.'s cash per share ranks #132 of 203 in the Health Care sector. Cash per Share returned to growth in FY2024 after 3 years of decline, reaching $1.18.
Based on SEC 10-K filings.
1.18 in FY2024 with a 3-year CAGR of -35.5%.
Improved from $0.92 to $1.18 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -35.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 203 in Health CareTop 65% of 203This company $1.18 Sector average $76.43
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 32.4% year-over-year.
- Ranks #132 out of 203 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.18 | +32.4% |
| FY2023 | $0.89 | -2.5% |
| FY2022 | $0.92 | -79.2% |
| FY2021 | $4.41 | -76.6% |
| FY2020 | $18.88 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026